Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01659528
Other study ID # CMC-11-0028-CTIL
Secondary ID
Status Withdrawn
Phase N/A
First received August 5, 2012
Last updated January 31, 2013
Start date July 2012
Est. completion date July 2014

Study information

Verified date January 2013
Source Carmel Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

The purpose of this study is to establish nomograms of penile length and width throughout the weeks of pregnancy.


Description:

Identifying pathology of male genitalia is important. It can be an isolated pathology, or connected to disorders in other organs, as part of genetic syndromes or endocrine disorders. Micropenis is a disorder, which is important to diagnose in the womb. Micropenis is defined as a penis which is measured 2.5 standard deviation below average. It is also thinner by diameter. This finding can also be the first expression of a lethal hormonal deficiency, hence the reason for early detection by ultrasound during pregnancy.

Past prenatal diagnosis ultrasound studies, measured the penis from the scrotum to the tip of the penis. Another study evaluated formalin fixated fetuses after pregnancy terminations, in which the penis was measured from the abdominal wall to the tip of the penis. To date there are no nomograms for penile length, via ultrasound measurement from abdominal wall or for penile width. The investigators assume that measuring the penis from the abdominal wall is more accurate and standard than from the end of the scrotum, which is a less definitive reference point.

The investigators aim to establish nomograms of penile length throughout the weeks of pregnancy. Exceptional penile width can also point out a problem with male genitalia. Therefore the investigators wish, as well to establish nomograms of penile width.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 2014
Est. primary completion date July 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Singleton pregnancy

- Proper pregnancy dating

- Normal fetal anatomical scan

- Gestational age 14 to 37 weeks

- Women aged 18 to 50

Exclusion Criteria:

- Multiple pregnancy

- Gestational age under 14 or above 37 weeks

- Fetus Small or Large for gestational age

- Abnormal anatomical scan or women who didn't perform such scan

- Minors

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Israel OBGYN Ultrasound Unit, Carmel Medical Center Haifa

Sponsors (1)

Lead Sponsor Collaborator
Carmel Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (4)

Aaronson IA. Micropenis: medical and surgical implications. J Urol. 1994 Jul;152(1):4-14. Review. — View Citation

Achiron R, Pinhas-Hamiel O, Zalel Y, Rotstein Z, Lipitz S. Development of fetal male gender: prenatal sonographic measurement of the scrotum and evaluation of testicular descent. Ultrasound Obstet Gynecol. 1998 Apr;11(4):242-5. — View Citation

Feldman KW, Smith DW. Fetal phallic growth and penile standards for newborn male infants. J Pediatr. 1975 Mar;86(3):395-8. — View Citation

Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Hum Reprod Update. 2001 May-Jun;7(3):282-6. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Penile length between 14 and 37 weeks gestation No
Primary Penile width between 14 and 37 weeks gestation No
See also
  Status Clinical Trial Phase
Recruiting NCT04755634 - Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement N/A